ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: GlaxoSmithKline

GSK pandemic flu shot may raise narcolepsy risks for adults

GSK pandemic flu shot may raise narcolepsy risks for adults

May 23, 2013 7:13 am by | 0 Comments

HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health ... Read more
GlaxoSmithKline gets unprecedented antiobiotics development deal with U.S.government

GlaxoSmithKline gets unprecedented antiobiotics development deal with U.S.government

May 22, 2013 7:01 am by | 0 Comments

LONDON, May 22 (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and ... Read more
Glaxo, Merck in plan to send vaccine to Africa

Glaxo, Merck in plan to send vaccine to Africa

May 10, 2013 4:30 am by | 0 Comments

Multinational drug companies, like other businesses, see Africa as an emerging market with tremendous opportunities and challenges, and that was a backdrop to Thursday's announcements of two programs designed to ... Read more
Merck, GSK cut price of cervical cancer shots for poor countries

Merck, GSK cut price of cervical cancer shots for poor countries

May 9, 2013 7:17 am by | 0 Comments

LONDON (Reuters) - Drugmakers Merck and GlaxoSmithKline have cut the price of cervical cancer shots in a deal that will deliver them to poor countries for less than $5 a ... Read more
Launch delays kill Impax and GSK partnership on Parkinson’s disease drug

Launch delays kill Impax and GSK partnership on Parkinson’s disease drug

April 29, 2013 9:07 am by | 0 Comments

(Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on Impax's experimental Parkinson's disease drug due to regulatory and launch delays in the countries in which GSK ... Read more
Glaxo may sell older drug brands in reorg of pharma groups

Glaxo may sell older drug brands in reorg of pharma groups

April 25, 2013 4:24 am by | 0 Comments

After reporting lower quarterly profits, drugmaker GlaxoSmithKline said Wednesday that it would reorganize its pharmaceutical divisions, with the possibility of someday selling older, "established" brands that it rarely promotes.Glaxo is ... Read more
GSK to partner with Avalon Ventures for drug discovery

GSK to partner with Avalon Ventures for drug discovery

April 22, 2013 7:37 pm by | 0 Comments

(Reuters) - GlaxoSmithKline said on Monday it will partner with venture capitalists Avalon Ventures in a deal worth up to $495 million to fund as many as 10 drug-discovery startup ... Read more
Astellas, GSK vie to make ‘high altitude’ anaemia pill

Astellas, GSK vie to make ‘high altitude’ anaemia pill

April 19, 2013 7:58 am by | 0 Comments

Japan's Astellas Pharma and Britain's GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at ... Read more
UK watchdog accuses GSK over pay-for-delay drug deals

UK watchdog accuses GSK over pay-for-delay drug deals

April 19, 2013 2:15 am by | 0 Comments

LONDON (Reuters) - Britain's antitrust watchdog said on Friday that GlaxoSmithKline and three generic drug companies had undermined competition by striking deals that paid the generic firms not to launch ... Read more
FDA panel recommends approval of Glaxo/Theravance lung drug for COPD

FDA panel recommends approval of Glaxo/Theravance lung drug for COPD

April 17, 2013 1:39 pm by | 0 Comments

April 17 (Reuters) - An advisory panel to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve an experimental treatment for smoking-related lung damage made by ... Read more
FDA reviewers say data for Glaxo’s BREO not consistent

FDA reviewers say data for Glaxo’s BREO not consistent

April 15, 2013 8:40 am by | 0 Comments

(Reuters) - Reviewers for the Food and Drug Administration said the efficacy data for GlaxoSmithKline Plc's and Theravance Inc's drug Breo for chronic obstructive pulmonary disease are "not entirely consistent."The ... Read more
FDA advisory panel to reconsider safety of diabetes drug Avandia

FDA advisory panel to reconsider safety of diabetes drug Avandia

April 12, 2013 5:19 pm by | 0 Comments

(Reuters) - A federal health advisory panel in June will reconsider safety data on GlaxoSmithKline Plc's Avandia diabetes drug, although the British drugmaker on Friday said it has not sought ... Read more
GSK plans $1M prize to jump-start “electroceuticals”

GSK plans $1M prize to jump-start “electroceuticals”

April 10, 2013 1:00 pm by | 0 Comments

GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body.

The company said on Wednesday it ... Read more

FDA delays approval of GSK bird flu vaccine

FDA delays approval of GSK bird flu vaccine

March 25, 2013 9:12 am by | 0 Comments

LONDON (Reuters) - Regulators have delayed approval of an H5N1 bird flu vaccine from GlaxoSmithKline, designed to be used in a pandemic.The vaccine had been backed by an expert panel ... Read more
GlaxoSmithKline boss says new drugs can be cheaper

GlaxoSmithKline boss says new drugs can be cheaper

March 14, 2013 11:15 am by | 0 Comments

LONDON (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to ... Read more